“Protein restriction and the hallmarks of aging: A coordinated physiological adaptive response?” – authored by Dr. Chris Morrison, Dr. Sora Kim and Dr. Sangho Yu of Pennington Biomedical – was recently published in the journal Cell Metabolism. The authors argue that the diverse effects of protein restriction, including changes in metabolism, glucose regulation, energy expenditure, growth and food preferences, should be viewed as interconnected components of a broader response to protein scarcity rather than as isolated biological pathways.

The perspective provides a framework for investigating how the body's response to protein scarcity may influence healthy aging and longevity and whether that response can be measured or ultimately targeted to improve health across the lifespan.

The unexplained results could enhance future efforts to study out-of-body experiences, researchers say.

On July 8, Korea University College of Medicine held the 1st Yale-Korea University Urology Symposium at Yukwangsa Hall on the second floor of the College of Medicine's main building.

Researchers at the University of Waterloo and University Health Network have developed MetaboSense, a new device that continuously monitors key indicators of donor lung health during ex vivo lung perfusion, a process used to assess lungs outside the body before transplantation. Unlike current methods that rely on hourly manual testing, MetaboSense provides real-time measurements of glucose and lactate levels, giving clinicians a more detailed picture of lung function and potentially helping them identify more viable donor lungs. The researchers believe the technology could reduce the number of donated lungs that are rejected, helping address organ shortages for patients with end-stage lung disease, while its modular design may also allow it to be adapted for monitoring other organs such as the liver, kidney, heart and pancreas.

Scientists, clinicians, and patient advocates from across the pediatric sarcoma community called for bridging cancer drug discovery and treatment through a unified clinical infrastructure. After meeting at Cold Spring Harbor Laboratory’s Banbury Center, the group outlined future research priorities and healthcare opportunities in an article for the journal Genes & Development.